Search company, investor...
Lyra Therapeutics company logo

Lyra Therapeutics

lyratherapeutics.com

Founded Year

2005

Stage

IPO | IPO

Total Raised

$164.58M

Date of IPO

5/1/2020

Market Cap

0.13B

Stock Price

3.91

About Lyra Therapeutics

Lyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases.

Headquarters Location

480 Arsenal Street

Watertown, Massachusetts, 02472,

United States

617-393-4600

Missing: Lyra Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Lyra Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Lyra Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lyra Therapeutics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,553 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Lyra Therapeutics Patents

Lyra Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Inflammations
  • Bones of the head and neck
  • Biomaterials
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/5/2019

2/15/2022

Fluid dynamics, Chemical properties, Biomaterials, Foams, Polymers

Grant

Application Date

4/5/2019

Grant Date

2/15/2022

Title

Related Topics

Fluid dynamics, Chemical properties, Biomaterials, Foams, Polymers

Status

Grant

Latest Lyra Therapeutics News

Pura Vida Investments Takes Passive Position in Lyra Therapeutics (LYRA)

Nov 9, 2022

Nasdaq By Fintel Fintel reportst thatPura Vida Investments, Llc has filed a 13G form with the SEC disclosing ownership of 2,782,091 shares of Lyra Therapeutics Inc (LYRA). This represents 8.74% of the company. In it's prior filing, the firm reported owning 520,544 shares, representing an increase of about 80%. The firm increased its portfolio allocation in LYRA by over 1,000% in the last quarter. AD AD Pura Vida Investments is a health care investment firm that invests in medtech, genomics, biopharmaceuticals, and health-tech.

Lyra Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Lyra Therapeutics Rank

Lyra Therapeutics Frequently Asked Questions (FAQ)

  • When was Lyra Therapeutics founded?

    Lyra Therapeutics was founded in 2005.

  • Where is Lyra Therapeutics's headquarters?

    Lyra Therapeutics's headquarters is located at 480 Arsenal Street, Watertown.

  • What is Lyra Therapeutics's latest funding round?

    Lyra Therapeutics's latest funding round is IPO.

  • How much did Lyra Therapeutics raise?

    Lyra Therapeutics raised a total of $164.58M.

  • Who are the investors of Lyra Therapeutics?

    Investors of Lyra Therapeutics include North Bridge Venture Partners, Polaris Partners, InterSouth Partners, ArrowMark Partners, Soleus Capital Management and 9 more.

  • Who are Lyra Therapeutics's competitors?

    Competitors of Lyra Therapeutics include Embolx, Tepha, Relievant Medsystems, Mobius Therapeutics, Belmont Instrument and 12 more.

Compare Lyra Therapeutics to Competitors

Belmont Instrument Logo
Belmont Instrument

Belmont Instrument developes devices in fluid management and cardiac assist.

C
C2C

C2C is a medical device company developing a portfolio of medical devices.

Femeda Logo
Femeda

Femeda is a UK based company focused on development of medical devices to treat incontinence and aims to offer solutions to conditions that can be accessed without visiting a healthcare professional.

Embolx Logo
Embolx

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures. The Sniper balloon occlusion microcatheter aims to set a new standard for precise embolic delivery and target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. The company was founded in 2013 and is based in Sunnyvale, California.

N
NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

S
SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.